Estadístiques de A randomized phase III study of abemaciclib versus erlotinib in patients with stage IV non-small cell lung cancer with a detectable KRAS mutation who failed prior platinum-based therapy: JUNIPER
Visites totals
| views | |
|---|---|
| A randomized phase III study of abemaciclib versus erlotinib in patients with stage IV non-small cell lung cancer with a detectable KRAS mutation who failed prior platinum-based therapy: JUNIPER | 100 |
Visites totals per mes
| views | |
|---|---|
| November 2024 | 1 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| goldman-frn-aran.pdf(legacy) | 99 |
| goldman-frn-aran.pdf | 36 |
Vistes principals per país
| views | |
|---|---|
| United States | 73 |
| Sweden | 4 |
| Spain | 3 |
| Greece | 3 |
| Ireland | 3 |
| Belgium | 2 |
| Italy | 2 |
| Australia | 1 |
| Germany | 1 |
| India | 1 |
| Iraq | 1 |
| Lithuania | 1 |
| Malaysia | 1 |
| Philippines | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 22 |
| Ann Arbor | 8 |
| Boardman | 6 |
| Fairfield | 5 |
| Mountain View | 4 |
| San Diego | 4 |
| Ashburn | 3 |
| Athens | 3 |
| Andover | 1 |
| Barcelona | 1 |
| Buffalo | 1 |
| Cambridge | 1 |
| Cupertino | 1 |
| Dallas | 1 |
| Las Palmas De Gran Canaria | 1 |
| Las Vegas | 1 |
| Los Angeles | 1 |
| Menlo Park | 1 |
| Monmouth Junction | 1 |
| Mumbai | 1 |
| Pasig | 1 |
| Pinjarra | 1 |
| Plankstadt | 1 |
| Redwood City | 1 |
| Seattle | 1 |
| Shah Alam | 1 |
| Stockholm | 1 |